SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-052233
Filing Date
2018-09-25
Accepted
2018-09-25 20:53:15
Documents
2
Period of Report
2018-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7107
2 POA DOCUMENT poa.txt EX-24.3_810779 3577
  Complete submission text file 0001209191-18-052233.txt   12112
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Tommasi Rubin (Reporting) CIK: 0001751824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38670 | Film No.: 181086737